PKCε Inhibitor Peptide acetate is a selective PKCε inhibitor containing the site for its specific receptor for activated C kinase (RACK). PKCε Inhibitor Peptide acetate inhibits the translocation of PKCε, but not α-, β-, and δPKC.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | Inquiry | $ 167 | |
4 mg | Inquiry | $ 283 | |
8 mg | Inquiry | $ 507 | |
20 mg | Inquiry | $ 864 | |
40 mg | Inquiry | $ 1304 |
Description | PKCε Inhibitor Peptide acetate is a selective PKCε inhibitor containing the site for its specific receptor for activated C kinase (RACK). PKCε Inhibitor Peptide acetate inhibits the translocation of PKCε, but not α-, β-, and δPKC. |
In vitro | PKCε Inhibitor Peptide acetate(1 µM; 24 hours) significantly inhibits Oleic acid-induced connexin 43 Ser368 phosphorylation and prevents Oleic acid-induced gap junction disassembly in cardiomyocytes. |
In vivo | In C57BL/6J mice transplanted the hearts of FVB mice, PKCε Inhibitor Peptide acetate (20 mg/kg/day; osmotic pumps s.c.) significantly improved the beating score throughout the treatment. PKCε Inhibitor Peptide acetate treatment almost abolished the rise in pro-fibrotic cytokine, TGF-β, and monocyte recruiting chemokine MCP-1 levels. PKCε Inhibitor Peptide acetate reduced the infiltration of macrophages and T cells into the cardiac grafts and decreased parenchymal fibrosis. |
Synonyms | PKCε Inhibitor Peptide acetate(182683-50-7 Free base) |
Chemical Formula | C39H69N9O15 |
Molecular Weight | 904.02 |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom